Keywords: generics, threaten, maturing, statin, market, report, cardiovascular

Generics threaten maturing statin market; report

Article | 18 April 2005

Print This

The cardiovascular drug arena - particularly, statins - is a hotbed of opportunity for generic drug manufacturers. At present, statins ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in